Qingdao Vland Biotech INC. (SHA:603739)

SHA:603739 Revenue

Qingdao Vland Biotech INC. had revenue of 387.16M CNY in the quarter ending September 30, 2026, with 6.48% growth. This brings the company's total for the last twelve months to 1.45B, up 4.04% year-over-year. In the year 2025, Qingdao Vland Biotech INC. had annual revenue of 1.37B with 3.43% growth. That makes Qingdao Vland Biotech INC. the 16,901st largest company in the world by revenue and 3,074th in China.

• Revenue (ttm): 1.45B
• Revenue Growth: +4.04%
• P/S Ratio: 2.14
• Revenue / Employee: 950.79K
• Employees: 1,522
• Market Cap: 3.10B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biology Division 954.44M 65.8%
• Movable Insurance Division 495.69M 34.2%

By Geography

Chart

• China 1.21B 90.8%
• Overseas 122.48M 9.2%

Fiscal year ended Dec 31, 2025 See the full SHA:603739 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.37B	45.36M	3.43%
Dec 31, 2024	1.32B	121.86M	10.16%
Dec 31, 2023	1.20B	35.74M	3.07%
Dec 31, 2022	1.16B	12.34M	1.07%
Dec 31, 2021	1.15B	190.57M	19.85%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error